SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-285070
Filing Date
2019-11-06
Accepted
2019-11-06 06:03:12
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d818805d10q.htm   iXBRL 10-Q 1431623
2 EX-31.1 d818805dex311.htm EX-31.1 10629
3 EX-31.2 d818805dex312.htm EX-31.2 10632
4 EX-32.1 d818805dex321.htm EX-32.1 6139
  Complete submission text file 0001193125-19-285070.txt   4559789

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20190930.xsd EX-101.SCH 26793
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20190930_cal.xml EX-101.CAL 29096
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20190930_def.xml EX-101.DEF 94750
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20190930_lab.xml EX-101.LAB 249134
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20190930_pre.xml EX-101.PRE 193042
43 EXTRACTED XBRL INSTANCE DOCUMENT d818805d10q_htm.xml XML 768745
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 191194942
SIC: 2834 Pharmaceutical Preparations